Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122250423 | 12225042 | 3 | F | 20160908 | 20160331 | 20160913 | EXP | CN-ROCHE-1733963 | ROCHE | WANG Y, YU Y, ZHUANG R, YU S, HOU J, JI Y, SUN Y, SHEN K, SHEN Z, LIU F, ZHAO N, LIU T. EFFICACY OF PREOPERATIVE CHEMOTHERAPY REGIMENS IN PATIENTS WITH INITIALLY UNRESECTABLE LOCALLY ADVANCED GASTRIC ADENOCARCINOMA: CAPECITABINE AND OXALIPLATIN (XELOX) OR WITH EPIRUBICIN (EOX) (4047). JOURNAL OF CLINICAL ONCOLOGY 2016 MAY;34(S15):-. | 0.00 | Y | 0.00000 | 20160913 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122250423 | 12225042 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | ON DAYS 1-14, | U | 20896 | TABLET | BID | |||||||
| 122250423 | 12225042 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | DAY 1, AS INTRAVENOUS 2 H INFUSION | U | 0 | 130 | MG/M**2 | INFUSION | ||||||
| 122250423 | 12225042 | 3 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Intravenous (not otherwise specified) | ON DAY 1 | U | 0 | 50 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122250423 | 12225042 | 1 | Gastric cancer |
| 122250423 | 12225042 | 2 | Gastric cancer |
| 122250423 | 12225042 | 3 | Gastric cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122250423 | 12225042 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122250423 | 12225042 | Anaemia | |
| 122250423 | 12225042 | Cardiac disorder | |
| 122250423 | 12225042 | Diarrhoea | |
| 122250423 | 12225042 | Fatigue | |
| 122250423 | 12225042 | Febrile neutropenia | |
| 122250423 | 12225042 | Hepatic function abnormal | |
| 122250423 | 12225042 | Leukopenia | |
| 122250423 | 12225042 | Mucosal inflammation | |
| 122250423 | 12225042 | Nausea | |
| 122250423 | 12225042 | Neuropathy peripheral | |
| 122250423 | 12225042 | Neutropenia | |
| 122250423 | 12225042 | Palmar-plantar erythrodysaesthesia syndrome | |
| 122250423 | 12225042 | Thrombocytopenia | |
| 122250423 | 12225042 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |